Shockwave Therapy
Extracorporeal Shockwave Therapy (ESWT) utilizes high-energy acoustic waves to create physical changes in target tissue through mechanotransduction. This mechanical stimulation induces controlled biological microtrauma, triggering growth factor release, localized cell signaling, angiogenesis (new blood vessel formation), and collagen remodeling. It effectively restarts the body’s natural healing cascade in chronic or non-healing tissue structures.
Clinical Indications & Patient Selection
Shockwave therapy is ideal for sub-acute and chronic conditions where tissue healing has plateaued, particularly soft tissues with poor vascularity:
Tendinopathies: Achilles tendinopathy, patellar tendinopathy, rotator cuff (calcific and non-calcific), lateral/medial epicondylitis.
Myofascial & Soft Tissue: Plantar fasciitis, trigger points, chronic myofascial restrictions.
Joint & Insertional Restrictions: Greater trochanteric pain, CMC joint restrictions, hamstring insertional tendinopathy.
Dual-Modality Synergy: Shockwave + Laser Therapy
Combining Extracorporeal Shockwave Therapy (ESWT) with High-Intensity Laser Therapy (HILT) produces a complementary therapeutic response by targeting separate stages of tissue repair:
Shockwave Therapy (Mechanotransduction): Initiates mechanical breakdown of degenerative tissue matrix, stimulates angiogenesis, and restarts the inflammatory healing cascade.
Laser Therapy (Photobiomodulation): Delivers targeted light wavelengths absorbed by mitochondrial chromophores (cytochrome c oxidase), stimulating ATP production, modulating cellular inflammation, increasing microcirculation, and reducing nociceptive signaling.
Combined Workflow Impact: Shockwave creates the stimulus to break down and rebuild structural tissue, while Laser fuels cellular energy for tissue repair and speeds recovery.”